APH vs TERN
Amphenol Corporation (APH) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
APH currently screens at market cap $170.77B and trailing P/E 39.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the APH and TERN stock pages for the full models.
Not investment advice.